NCT03421132View on ClinicalTrials.gov

Multiple Myeloma Molecular Monitoring Study

Active, not recruitingOBSERVATIONAL
Enrollment

96

Participants

Timeline

Start Date

February 20, 2018

Primary Completion Date

December 31, 2024

Study Completion Date

March 31, 2026

Conditions
Multiple Myeloma
Trial Locations (9)

T2N 4N2

Tom Baker Cancer Centre, Calgary

T6G 1Z2

Cross Cancer Institute, Edmonton

V5Z 1M9

Vancouver General Hospital, Vancouver

R3E 0V9

CancerCare Manitoba, Winnipeg

E2L 4L5

Saint John Regional Hospital (Horizon Health Network), Saint John

B3H 2Y9

Queen Elizabeth II Health Sciences Centre, Halifax

L8V 1C3

Buland Mangukia, Hamilton

M5G 1X6

Princess Margaret Cancer Centre, Toronto

H4A 3J1

McGill University Health Centre, Montreal

All Listed Sponsors
lead

Horizon Health Network

OTHER

NCT03421132 - Multiple Myeloma Molecular Monitoring Study | Biotech Hunter | Biotech Hunter